Trial Profile
A Multicenter Study To Evaluate The Efficacy and Safety of Daclatasvir and Asunaprevir on Early Hepatitis C Virus Kinetics in Patients With Hepatitis C.
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 10 Mar 2016
Price :
$35
*
At a glance
- Drugs Asunaprevir (Primary) ; Daclatasvir (Primary)
- Indications Hepatitis C
- Focus Adverse reactions; Therapeutic Use
- 11 Aug 2015 New trial record